AZN vs UBER · P/E 28, $288.38B cap vs P/E 18, rev $52.02B
AstraZeneca PLC (AZN) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
AZN does not have a complete income-statement cache yet.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the AZN and UBER stock pages for the full models.
Not investment advice.